Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction

Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV). The binding of SARS-CoV spike (S) protein to cellular angiotensin-converting enzyme 2 (ACE2) is the first step in SARS-CoV infection. Therefore, we assayed the inhibitory effects of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Tin-Yun, Wu, Shih-Lu, Chen, Jaw-Chyun, Wei, Yen-Chiao, Cheng, Shin-Ei, Chang, Yung-Hsien, Liu, Hsu-Jan, Hsiang, Chien-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114127/
https://www.ncbi.nlm.nih.gov/pubmed/16337697
http://dx.doi.org/10.1016/j.antiviral.2005.10.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114127/
https://www.ncbi.nlm.nih.gov/pubmed/16337697
http://dx.doi.org/10.1016/j.antiviral.2005.10.005

Ejemplares similares